by SpiSafConf | Jul 11, 2022 | Ayahuasca, Bipolar Disorder, Cancer, Iboga, Kambo, MDMA Sassafras Molly, Psychedelic Medicine, Psychotropics
Remember that psychedelic substances are illegal in most jurisdictions. If you have physical or mental health issues, speak to a mental health professional before experimenting with psychedelics. Ensure you are in a physically safe, controlled environment. Always...
by SpiSafConf | Jul 5, 2022 | Ayahuasca, Iboga, Kambo, LSD, Psychedelic Medicine, Psychotropics, PTSD, San Pedro Mescaline
What are the most common natural psychedelics? The natural world is full of psychedelic and other psychoactive substances. In fact, most synthetic psychedelics are derived or inspired by naturally-occurring substances. Many natural psychedelics are considered...
by SpiSafConf | Jul 2, 2022 | CBC, Iboga, Kambo, MDMA Sassafras Molly, Microdosing, Neuropathy, NN-Dimethyltryptamine, OCD, Pain, Parkinson's Disease, Psilocybin Magic Mushroom, Psychedelic Medicine, Psychotropics
There are many benefits to consuming psilocybin magic mushrooms, and they have been used in many cultures around the world for thousands of years. Studies have shown “a single dose of psilocybin produced substantial and enduring decreases in depressed mood and anxiety...
by SpiSafConf | Jul 1, 2022 | Bipolar Disorder, Iboga, Kambo, LSD, MDMA Sassafras Molly, Psilocybin Magic Mushroom, Psychedelic Medicine, Psychotropics, PTSD
Companies like Compass Pathways, which uses psilocybin for depression, and Atai Life Sciences, are researching a variety of ways to treat mental health with alternative and psychedelic therapies. On top of that, the decriminalization and legalization of drugs like...
by SpiSafConf | Jul 1, 2022 | Cannabis Marijuana, Iboga, Kambo, LSD, MDMA Sassafras Molly, Microdosing, Neuropathy, NN-Dimethyltryptamine, OCD, Pain, Parkinson's Disease, Psilocybin Magic Mushroom
3,4-Methylenedioxymethamphetamine (MDMA), commonly known as ecstasy, alleviated post-traumatic stress disorder (PTSD) in a phase 3 trial and was a milestone in the efforts to turn psychedelic drugs into mainstream treatments. 67% of the 42 people who got MDMA no...
